Tianyin Pharmaceutical Co. Inc. (TPI) Posts Q2 FY2011 Financial Results

QualityStocks would like to highlight Tianyin Pharmaceutical Co., Inc. (NYSE AMEX: TPI). Headquartered at Chengdu, China, the company specializes in the development, manufacturing, marketing, and sale of patented biopharmaceutical, modernized traditional Chinese medicines, branded generics, and other pharmaceuticals.

In the company’s news yesterday,

Tianyin Pharmaceutical announced its financial results for the second quarter of fiscal year 2011.

Revenue for the second quarter ended December 31, 2010, increased 69.6 percent to $25.3 million from $14.9 million in the second quarter of ended December 31, 2009. Cost of sales for the second quarter were $14.0 million, or 55.3 percent of sales, as compared to %7.2 million, or 48.3 percent of the sales quarter of 2009.

Gross margin for the quarter ended December 31, 2010, was 44.7 percent as compared to 51.9 percent for the quarter ended December 31, 2009. The company attributes the figures to the addition of revenues from Tianyin Medicine Trading (TMT), the distribution arm of TPI, in the current year.

Operating expenses for the second quarter were $6.0 million, compared with $4.6 million for the quarter ended December 31, 2009.

Net income increased 69.2 percent to million to $4.4 million, or $0.14 diluted earnings per share, for the quarter ended December 31, 2010, as compared to net income of $2.6 million, or $0.08 per diluted share, for the quarter ended December 31, 2009.

As of December 31, 2010, Tianyin reported working capital totaling $35.7 million, including cash and cash equivalents of $31.2 million or $1.11 per share in cash.

The company noted it has 10 pipeline drugs pending SFDA’s approval and reiterated its fiscal year 2011 revenue guidance of $113.0 million, representing 76.8 percent year-over-year sales growth and net income guidance of $18.0 million, representing 50.0 percent year-over-year profit growth.

About QualityStocks

QualityStocks, based in Scottsdale, Arizona, is a free service that collects data from hundreds of Small-Cap and Micro-Cap online Investment Newsletters into one Daily Newsletter Report. QualityStocks is dedicated to assisting emerging public companies with their investor communication efforts and connecting subscribers with companies that have huge potential to succeed in the short and long-term future.

To sign up for “The QualityStocks Daily Newsletter” please visit www.QualityStocks.net

Please see disclaimer on QualityStocks website: http://Disclaimer.QualityStocks.net

Forward-Looking Statement:

This release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. Risks and uncertainties applicable to the company and its business could cause the company's actual results to differ materially from those indicated in any forward-looking statements.